CDC Lowers Age for First Pneumococcal Vaccine to 50
Medically reviewed by Drugs.com.
By Ernie Mundell HealthDay Reporter
THURSDAY, Oct. 24, 2024 -- The recommended first age at which Americans should get the pneumococcal vaccine has been lowered from 65 to 50, the U.S. Centers for Disease Control and Prevention announced Wednesday.
"Lowering the age for pneumococcal vaccination gives more adults the opportunity to protect themselves from pneumococcal disease at the age when risk of infection substantially increases," CDC director Dr. Mandy Cohen said in an agency statement.
"Pneumococcal bacteria can cause serious illnesses, including pneumonia, meningitis, and bloodstream infections, and older adults are at increased risk for pneumococcal disease," she explained.
Earlier yesterday, the CDC advisory panel had previously voted 14 to 1 to lower the vaccination age, and Cohen approved the move soon after.
Prior recommendations had advised the pneumococcal shot for two vulnerable age groups: children under the age of 5 and seniors age 65 and older. People of other ages with certain health conditions are also advised to get the shot.
Pneumococcal disease is caused by Streptococcus pneumoniae and related forms of pneumococci bacteria.
"Over 150,000 hospitalizations from pneumococcal pneumonia are estimated to occur annually in the United States and it has been demonstrated to complicate influenza infection," according to the CDC.
"Pneumococci is the most common bacterial cause of childhood pneumonia, especially in children younger than age 5 years," the agency noted. "In adults, pneumococci account for 10% to 30% of adult community-acquired pneumonia."
The very first pneumococcal vaccine was licensed in the United States in 1977.
According to the Associated Press, there are four types of pneumococcal vaccine available to Americans, including Capvaxive, made by Merck, which can cost around $300 a dose and protects against 21 types of pneumococci, eight more than other vaccines.
The CDC advisory panel noted that pneumococcal illness tends to appear earlier in Black Americans -- between 55 and 59 years of age -- compared to whites. That was part of the experts' reasoning that the age of first vaccination should be lowered, the AP reported.
It's possible that booster shots of the vaccine may be required about 15 years after the first shot.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-25 00:00
Read more
- Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma
- Merus Receives FDA Extension of PDUFA for Zenocutuzumab
- Judge Declares Wyoming's Abortion Bans Unconstitutional
- Monthly News Roundup - October 2024
- Anxiety/Depression Linked to HRQoL Losses in Seropositive RA
- Satsuma Pharmaceuticals and SNBL Resubmits the New Drug Application for STS101 (Dihydroergotamine Nasal Powder) for the Acute Treatment of Migraine With or Without Aura
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions